BeiGene Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BGNE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 Jun 24	SellUS$445,070	John Oyler	Individual	2,789	US$160.12
24 Jun 24	SellUS$233,133	Xiaobin Wu	Individual	1,459	US$161.27
24 Jun 24	SellUS$139,938	Julia Wang	Individual	899	US$155.66
24 Jun 24	SellUS$170,030	Wang Lai	Individual	1,064	US$161.10
18 Jun 24	SellUS$368,162	Wang Lai	Individual	2,341	US$159.90
18 Jun 24	SellUS$505,208	Xiaobin Wu	Individual	3,254	US$159.00
17 Jun 24	SellUS$69,955	Chan Lee	Individual	439	US$159.74
17 Jun 24	SellUS$204,125	John Oyler	Individual	1,281	US$159.91
17 Jun 24	SellUS$145,678	Julia Wang	Individual	916	US$159.74
11 Apr 24	SellUS$7,475,024	John Oyler	Individual	50,000	US$154.21
29 Feb 24	SellUS$66,331	Julia Wang	Individual	397	US$167.08
26 Jan 24	BuyUS$23,699,905	Capital Research and Management Company	Company	146,849.93	US$161.39
14 Nov 23	SellUS$198,550,000	Baker Bros. Advisors LP	Company	1,100,000	US$180.50
02 Aug 23	BuyUS$544,881	Capital Research and Management Company	Company	33,854.3	US$16.09
31 Jul 23	SellUS$171,059	Chan Lee	Individual	791	US$216.26
03 Jul 23	SellUS$84,747	Julia Wang	Individual	472	US$179.55

Insider Buying: BGNE insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 79.59% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18%	Amgen Inc.	18,938,119	US$2.8b	0%	no data
10%	Baker Bros. Advisors LP	10,576,082	US$1.6b	0%	19.09%
9.45%	HHLR Advisors, Ltd.	9,955,172	US$1.5b	0%	27.76%
7.99%	Capital Research and Management Company	8,414,438	US$1.2b	10.7%	0.07%
4.91%	Hillhouse Investment Management, Ltd.	5,177,085	US$761.0m	-52.9%	6.68%
4.75%	PRIMECAP Management Company	5,001,839	US$735.3m	0.26%	0.56%
3.75%	Baillie Gifford & Co.	3,946,611	US$580.1m	-3.61%	0.28%
3.5%	John Oyler	3,690,133	US$542.4m	-8.98%	no data
2.86%	Temasek Holdings (Private) Limited	3,014,171	US$443.1m	0%	0.46%
2.74%	BlackRock, Inc.	2,890,166	US$424.8m	0.84%	0.01%
1.92%	T. Rowe Price Group, Inc.	2,026,340	US$297.9m	6.18%	0.03%
1.87%	The Vanguard Group, Inc.	1,974,042	US$290.2m	0.45%	no data
1.56%	FMR LLC	1,640,879	US$241.2m	-3.96%	0.02%
1.19%	Bosera Asset Management Co., Ltd.	1,252,593	US$184.1m	0%	1.09%
0.86%	Xiaodong Wang	901,634	US$132.5m	11.9%	no data
0.81%	GF Fund Management Co., Ltd.	848,181	US$124.7m	0%	0.33%
0.51%	ICBC Credit Suisse Asset Management Co., Ltd.	533,770	US$78.5m	0%	0.62%
0.47%	Tavistock Life Sciences	500,000	US$73.5m	0%	4.19%
0.42%	China Asset Management Co. Ltd.	445,317	US$65.5m	3.72%	0.11%
0.38%	Artal Group S.A.	404,782	US$59.5m	0.07%	1.58%
0.35%	Guangzhou Development District Holding Group Limited	368,385	US$54.2m	0%	no data
0.35%	SDIC Unity Capital Co., Ltd.	368,385	US$54.2m	0%	5.78%
0.34%	Public Investment Fund	354,385	US$52.1m	0%	0.03%
0.31%	Vestal Point Capital, LP	325,000	US$47.8m	0%	4.58%
0.29%	Wanjia Asset Management Co., Ltd.	307,600	US$45.2m	0%	0.85%